2023-06-012024-05-312024-05-31false12619770NOVAZERA LIMITED2025-02-11falseiso4217:GBPxbrli:pure126197702023-06-01126197702024-05-31126197702023-06-012024-05-31126197702022-06-01126197702023-05-31126197702022-06-012023-05-3112619770bus:SmallEntities2023-06-012024-05-3112619770bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3112619770bus:FullAccounts2023-06-012024-05-3112619770bus:PrivateLimitedCompanyLtd2023-06-012024-05-3112619770core:WithinOneYear2024-05-3112619770core:AfterOneYear2024-05-3112619770core:WithinOneYear2023-05-3112619770core:AfterOneYear2023-05-3112619770core:ShareCapital2024-05-3112619770core:SharePremium2024-05-3112619770core:RevaluationReserve2024-05-3112619770core:OtherReservesSubtotal2024-05-3112619770core:RetainedEarningsAccumulatedLosses2024-05-3112619770core:ShareCapital2023-05-3112619770core:SharePremium2023-05-3112619770core:RevaluationReserve2023-05-3112619770core:OtherReservesSubtotal2023-05-3112619770core:RetainedEarningsAccumulatedLosses2023-05-3112619770core:LandBuildings2024-05-3112619770core:PlantMachinery2024-05-3112619770core:Vehicles2024-05-3112619770core:FurnitureFittings2024-05-3112619770core:OfficeEquipment2024-05-3112619770core:NetGoodwill2024-05-3112619770core:IntangibleAssetsOtherThanGoodwill2024-05-3112619770core:ListedExchangeTraded2024-05-3112619770core:UnlistedNon-exchangeTraded2024-05-3112619770core:LandBuildings2023-05-3112619770core:PlantMachinery2023-05-3112619770core:Vehicles2023-05-3112619770core:FurnitureFittings2023-05-3112619770core:OfficeEquipment2023-05-3112619770core:NetGoodwill2023-05-3112619770core:IntangibleAssetsOtherThanGoodwill2023-05-3112619770core:ListedExchangeTraded2023-05-3112619770core:UnlistedNon-exchangeTraded2023-05-3112619770core:LandBuildings2023-06-012024-05-3112619770core:PlantMachinery2023-06-012024-05-3112619770core:Vehicles2023-06-012024-05-3112619770core:FurnitureFittings2023-06-012024-05-3112619770core:OfficeEquipment2023-06-012024-05-3112619770core:NetGoodwill2023-06-012024-05-3112619770core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3112619770core:ListedExchangeTraded2023-06-012024-05-3112619770core:UnlistedNon-exchangeTraded2023-06-012024-05-3112619770core:MoreThanFiveYears2023-06-012024-05-3112619770core:Non-currentFinancialInstruments2024-05-3112619770core:Non-currentFinancialInstruments2023-05-3112619770dpl:CostSales2023-06-012024-05-3112619770dpl:DistributionCosts2023-06-012024-05-3112619770core:LandBuildings2023-06-012024-05-3112619770core:PlantMachinery2023-06-012024-05-3112619770core:Vehicles2023-06-012024-05-3112619770core:FurnitureFittings2023-06-012024-05-3112619770core:OfficeEquipment2023-06-012024-05-3112619770dpl:AdministrativeExpenses2023-06-012024-05-3112619770core:NetGoodwill2023-06-012024-05-3112619770core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3112619770dpl:GroupUndertakings2023-06-012024-05-3112619770dpl:ParticipatingInterests2023-06-012024-05-3112619770dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3112619770core:ListedExchangeTraded2023-06-012024-05-3112619770dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3112619770core:UnlistedNon-exchangeTraded2023-06-012024-05-3112619770dpl:CostSales2022-06-012023-05-3112619770dpl:DistributionCosts2022-06-012023-05-3112619770core:LandBuildings2022-06-012023-05-3112619770core:PlantMachinery2022-06-012023-05-3112619770core:Vehicles2022-06-012023-05-3112619770core:FurnitureFittings2022-06-012023-05-3112619770core:OfficeEquipment2022-06-012023-05-3112619770dpl:AdministrativeExpenses2022-06-012023-05-3112619770core:NetGoodwill2022-06-012023-05-3112619770core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3112619770dpl:GroupUndertakings2022-06-012023-05-3112619770dpl:ParticipatingInterests2022-06-012023-05-3112619770dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3112619770core:ListedExchangeTraded2022-06-012023-05-3112619770dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3112619770core:UnlistedNon-exchangeTraded2022-06-012023-05-3112619770core:NetGoodwill2024-05-3112619770core:IntangibleAssetsOtherThanGoodwill2024-05-3112619770core:LandBuildings2024-05-3112619770core:PlantMachinery2024-05-3112619770core:Vehicles2024-05-3112619770core:FurnitureFittings2024-05-3112619770core:OfficeEquipment2024-05-3112619770core:AfterOneYear2024-05-3112619770core:WithinOneYear2024-05-3112619770core:ListedExchangeTraded2024-05-3112619770core:UnlistedNon-exchangeTraded2024-05-3112619770core:ShareCapital2024-05-3112619770core:SharePremium2024-05-3112619770core:RevaluationReserve2024-05-3112619770core:OtherReservesSubtotal2024-05-3112619770core:RetainedEarningsAccumulatedLosses2024-05-3112619770core:NetGoodwill2023-05-3112619770core:IntangibleAssetsOtherThanGoodwill2023-05-3112619770core:LandBuildings2023-05-3112619770core:PlantMachinery2023-05-3112619770core:Vehicles2023-05-3112619770core:FurnitureFittings2023-05-3112619770core:OfficeEquipment2023-05-3112619770core:AfterOneYear2023-05-3112619770core:WithinOneYear2023-05-3112619770core:ListedExchangeTraded2023-05-3112619770core:UnlistedNon-exchangeTraded2023-05-3112619770core:ShareCapital2023-05-3112619770core:SharePremium2023-05-3112619770core:RevaluationReserve2023-05-3112619770core:OtherReservesSubtotal2023-05-3112619770core:RetainedEarningsAccumulatedLosses2023-05-3112619770core:NetGoodwill2022-06-0112619770core:IntangibleAssetsOtherThanGoodwill2022-06-0112619770core:LandBuildings2022-06-0112619770core:PlantMachinery2022-06-0112619770core:Vehicles2022-06-0112619770core:FurnitureFittings2022-06-0112619770core:OfficeEquipment2022-06-0112619770core:AfterOneYear2022-06-0112619770core:WithinOneYear2022-06-0112619770core:ListedExchangeTraded2022-06-0112619770core:UnlistedNon-exchangeTraded2022-06-0112619770core:ShareCapital2022-06-0112619770core:SharePremium2022-06-0112619770core:RevaluationReserve2022-06-0112619770core:OtherReservesSubtotal2022-06-0112619770core:RetainedEarningsAccumulatedLosses2022-06-0112619770core:AfterOneYear2023-06-012024-05-3112619770core:WithinOneYear2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:CostValuation2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3112619770core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3112619770core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3112619770core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3112619770core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3112619770core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3112619770bus:Director12023-06-012024-05-3112619770bus:Director22023-06-012024-05-3112619770bus:Director32023-06-012024-05-31

NOVAZERA LIMITED

Registered Number
12619770
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2024

NOVAZERA LIMITED
Company Information
for the year from 1 June 2023 to 31 May 2024

Directors

MARCHANT, Russell
POWELL, Brian John
SEVILLE, James Lee

Company Secretary

SEVILLE, Margaret Ann

Registered Address

Hartpury University Hartpury House
Hartpury
Gloucester
GL19 3BE

Registered Number

12619770 (England and Wales)
NOVAZERA LIMITED
Balance Sheet as at
31 May 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors3100166
Cash at bank and on hand120215
220381
Creditors amounts falling due within one year4(12,558)(11,688)
Net current assets (liabilities)(12,338)(11,307)
Total assets less current liabilities(12,338)(11,307)
Net assets(12,338)(11,307)
Capital and reserves
Called up share capital100100
Profit and loss account(12,438)(11,407)
Shareholders' funds(12,338)(11,307)
The financial statements were approved and authorised for issue by the Board of Directors on 11 February 2025, and are signed on its behalf by:
SEVILLE, James Lee
Director
Registered Company No. 12619770
NOVAZERA LIMITED
Notes to the Financial Statements
for the year ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Interest income
Interest income is recognised using the effective interest rate method.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year00
3.Debtors: amounts due within one year

2024

2023

££
Other debtors100166
Total100166
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables2,6403,640
Other creditors9,9186,554
Accrued liabilities and deferred income-1,494
Total12,55811,688
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.